Register now for Pharmacology Update 2022, Saturday, September 24th. Why? Can you apply guideline recommendations & clinical trial outcomes to strategies that reduce risks for CVD events & other related co-morbidities?
Jane Kapustin, PhD, CRNP, BC-ADM, FAANP, FAAN, provides patient care to complex patients with diabetes (type 1 & 2) and/or endocrinology disorders. Serves in leadership position to manage the day-to-day activities of 3 private practice sites associated with Riverside Medical.
Dr. Jane Kapustin has been seeing patients with diabetes for over 35 years. Prior to joining Riverside Medical, she was a professor and an assistant dean for advanced practice NP programs at the University of MD in Baltimore. She continued to see patients at the University of MD Center for Diabetes and Endocrinology (formerly Joslin Diabetes Center) as part of her faculty practice. She also had numerous years of service in primary care and women’s health before working at University of MD. She is board certified as an adult NP and in Advanced Diabetes Management (BC-ADM), has published over 50 articles and 15 book chapters, mostly in the field of diabetes, completed numerous funded research projects, and is a requested presenter for regional and national conferences. Dr. Kapustin is also a past president of the Nurse Practitioner Association of Maryland (NPAM). She was inducted as a fellow in the American Association of Nurse Practitioners and the American Academy of Nursing.
New this year, as well as the in-person conference, we will be offering live streaming on Zoom.
September 24, 2022
Anne Arundel Community College
This education activity has been submitted to the American Association of Nurse Practitioners for approval of 7.0 contact hours of continuing education (which includes 6.3 hours pharmacology).
Thank you to our Industry and Pharmaceutical partners who continue to provide us with up-to-date information, new products, and practice information (Click for more information).